Thyroid Hormone Status in Sitosterolemia is Modified by Ezetimibe

OBJECTIVES: To assess the association between biomarkers of thyroid status and 5α-stanols in sitosterolemia (STSL) patients treated with ezetimibe (EZE). STUDY DESIGN: Eight STSL patients (16-56 years) were studied during 14 weeks off EZE therapy (OFF EZE) and 14 weeks on EZE (10 mg/d; ON EZE). Seru...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Pediatr
Main Authors: Othman, Rgia A., Myrie, Semone B., Mymin, David, Roullet, Jean-Baptiste, DeBarber, Andrea E., Steiner, Robert D., Jones, Peter J.H.
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5572543/
https://ncbi.nlm.nih.gov/pubmed/28625503
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpeds.2017.05.049
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki